(Q34447506)

2 August 2017

Simple non-invasive biomarkers of advanced fibrosis in the evaluation of non-alcoholic fatty liver disease (English)

1 reference

non-alcoholic fatty liver

2 August 2017

0 references

1 reference

based on heuristic

inferred from title

metabolic dysfunction–associated steatotic liver disease

1 reference

Nezam Afdhal

6

0 references

author name string

Elliot B Tapper

1

1 reference

2 August 2017

Katherine Krajewski

2

1 reference

2 August 2017

Michelle Lai

3

1 reference

2 August 2017

Tracy Challies

4

1 reference

2 August 2017

Robert Kane

5

1 reference

2 August 2017

Daryl Lau

7

1 reference

2 August 2017

7 July 2014

1 reference

2 August 2017

Gastroenterology report

1 reference

2 August 2017

2

1 reference

2 August 2017

4

1 reference

2 August 2017

276-280

1 reference

Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitis.

2 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219143

Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219143

The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219143

Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219143

The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219143

Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219143

Long-term follow-up of patients with NAFLD and elevated liver enzymes

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219143

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219143

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219143

Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219143

Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study.

6 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1093%2FGASTRO%2FGOU034

Noninvasive laboratory tests proposed for predicting cirrhosis in patients with chronic hepatitis C are also useful in patients with non-alcoholic steatohepatitis

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1093%2FGASTRO%2FGOU034

Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1093%2FGASTRO%2FGOU034

APRI: a simple bedside marker for advanced fibrosis that can avoid liver biopsy in patients with NAFLD/NASH.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4219143

The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD

27 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25002154

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1093/GASTRO/GOU034

1 reference

2 August 2017

1 reference

2 August 2017

1 reference